IAEA9月理事会（議題6 原子力科学技術応用活動の強化）ステートメント（引原毅大使）（英語）
令和4年9月13日
Thank you, Chair,
Japan thanks the Secretariat for preparing a comprehensive and informative report on this such item.
The peaceful uses of nuclear science, technology and applications can make a tangible contribution to effectively addressing imminent global challenges and facilitate the implementation of the 2030 Agenda for the SDGs.
Japan highly appreciates the IAEA’s long-standing contribution to the promotion of peaceful uses of nuclear energy and its active engagement in addressing emerging challenges including the COVID-19 pandemic. This is the reason why Japan stressed the indispensable role of the IAEA at the NPT Review conference this August, expressing our strong support to the IAEA’s initiatives, including ZODIAC, NUTEC Plastics and Rays of Hope.
Chair,
Japan considers the ZODIAC initiative to be a valuable endeavor to systematically strengthen the global capability to tackle zoonotic diseases taking lessons from the COVID-19 pandemic.
We highly appreciate the ZODIAC online workshop on Monkeypox and Lassa fever Infections, hosted by the IAEA in June this year, as a timely response to the rapid spread of these zoonotic diseases. With the wide participation from all over the world, including the FAO and the WHO as well as ZODIAC National Laboratory experts, the workshop showed a real potential of networking and working together among various international and national key players. Japan welcomes the remarkable expansion of the network of ZODIAC stakeholders, which enables them to respond to dramatic changes during a pandemic situation in a agile, efficient and coordinated manner.
The Japanese government has contributed 11 million euros to the IAEA for the fight against COVID-19 and the ZODIAC initiative. We are pleased that our contribution has been helping 38 ZODIAC National Laboratories to acquire necessary equipment for capacity building. Japanese contribution has also financed an expert post at the IAEA’s laboratory for fellowship training on zoonotic diseases for Member States.
Chair,
Japan highly appreciates the Rays of Hope initiative as a means to strengthen the capacity of the Agency and Member States in cancer diagnosis and treatment.
Japan has various technologies related to radiotherapy, and is planning to organize two side events on the margins of the upcoming IAEA General Conference: one on medical radioisotopes and the other on Boron Neutron Capture Therapy (BNCT). Let me briefly touch upon each of them.
First, medical radioisotopes are used in major clinical areas for diagnosis and therapy. The IAEA’s efforts in this regard are important, especially in supporting Member States in the development of production capacity, training courses and education programmes. Japan responded to the growing international interest in medical radioisotopes by publishing the Action Plan for their production and utilization this May. Japan hopes to strengthen our cooperation with the IAEA for the development and global supply of medical radioisotopes.
Second, the Boron Neutron Capture Therapy (BNCT) is a promising treatment method with a low level of irradiation that does not damage adjoining normal tissue. Japanese experts have contributed to the creation of international guidelines for the BNCT, in close cooperation with the IAEA and other partners. Japan will continue to collaborate with the IAEA for development of this promising BNCT technology and its applications, as well as transfer of the related knowledge to other Member States.
We sincerely hope that our cooperation with the IAEA in medical radioisotopes and the BNCT, including these two side events at the GC, will contribute to the enhancement of cancer treatment in Member States, in particular developing countries.
Chair,
With these comments, Japan takes note of the Agency’s report, GOV/2022/30-GC (66)/9.
Thank you, Chair.
Japan thanks the Secretariat for preparing a comprehensive and informative report on this such item.
The peaceful uses of nuclear science, technology and applications can make a tangible contribution to effectively addressing imminent global challenges and facilitate the implementation of the 2030 Agenda for the SDGs.
Japan highly appreciates the IAEA’s long-standing contribution to the promotion of peaceful uses of nuclear energy and its active engagement in addressing emerging challenges including the COVID-19 pandemic. This is the reason why Japan stressed the indispensable role of the IAEA at the NPT Review conference this August, expressing our strong support to the IAEA’s initiatives, including ZODIAC, NUTEC Plastics and Rays of Hope.
Chair,
Japan considers the ZODIAC initiative to be a valuable endeavor to systematically strengthen the global capability to tackle zoonotic diseases taking lessons from the COVID-19 pandemic.
We highly appreciate the ZODIAC online workshop on Monkeypox and Lassa fever Infections, hosted by the IAEA in June this year, as a timely response to the rapid spread of these zoonotic diseases. With the wide participation from all over the world, including the FAO and the WHO as well as ZODIAC National Laboratory experts, the workshop showed a real potential of networking and working together among various international and national key players. Japan welcomes the remarkable expansion of the network of ZODIAC stakeholders, which enables them to respond to dramatic changes during a pandemic situation in a agile, efficient and coordinated manner.
The Japanese government has contributed 11 million euros to the IAEA for the fight against COVID-19 and the ZODIAC initiative. We are pleased that our contribution has been helping 38 ZODIAC National Laboratories to acquire necessary equipment for capacity building. Japanese contribution has also financed an expert post at the IAEA’s laboratory for fellowship training on zoonotic diseases for Member States.
Chair,
Japan highly appreciates the Rays of Hope initiative as a means to strengthen the capacity of the Agency and Member States in cancer diagnosis and treatment.
Japan has various technologies related to radiotherapy, and is planning to organize two side events on the margins of the upcoming IAEA General Conference: one on medical radioisotopes and the other on Boron Neutron Capture Therapy (BNCT). Let me briefly touch upon each of them.
First, medical radioisotopes are used in major clinical areas for diagnosis and therapy. The IAEA’s efforts in this regard are important, especially in supporting Member States in the development of production capacity, training courses and education programmes. Japan responded to the growing international interest in medical radioisotopes by publishing the Action Plan for their production and utilization this May. Japan hopes to strengthen our cooperation with the IAEA for the development and global supply of medical radioisotopes.
Second, the Boron Neutron Capture Therapy (BNCT) is a promising treatment method with a low level of irradiation that does not damage adjoining normal tissue. Japanese experts have contributed to the creation of international guidelines for the BNCT, in close cooperation with the IAEA and other partners. Japan will continue to collaborate with the IAEA for development of this promising BNCT technology and its applications, as well as transfer of the related knowledge to other Member States.
We sincerely hope that our cooperation with the IAEA in medical radioisotopes and the BNCT, including these two side events at the GC, will contribute to the enhancement of cancer treatment in Member States, in particular developing countries.
Chair,
With these comments, Japan takes note of the Agency’s report, GOV/2022/30-GC (66)/9.
Thank you, Chair.